Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Incyte Corporation (INCY) vs Lemonade Inc (LMND) Price & Performance

Incyte CorporationTrade
Lemonade IncTrade

Price performance (Past 24H)

Key statistics

Incyte Corporation vs Lemonade Inc — how do they compare? Incyte Corporation trades at $115.7 (market cap $23.11B), while Lemonade Inc trades at $68.99 (market cap $5.18B). The key difference: Incyte Corporation is far larger — about 4.5× Lemonade Inc's market cap, and Incyte Corporation is trading nearer its 52-week high, Lemonade Inc nearer its low. Which is the better fit depends on your goals.

INCYLMND
Market Cap
$23.11B$5.18B
Sector
HealthFinancials
52-Week High
$118.52$96.57
52-Week Low
$67.38$36.28
Enterprise Value
$19.13B$5.01B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Incyte Corporation

Incyte focuses on the discovery and development of small-molecule drugs. The firm's lead drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis. Incyte's pipeline includes a broad array of oncology and dermatology programs.

Read more on INCY

About Lemonade Inc

Lemonade Inc operates in the insurance industry. The company offers digital and artificial intelligence based platform for various insurances and for settling claims and paying premiums. The platform ensures transparency in issuing policies and settling disputes.

Read more on LMND